Dynulta Tablet
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Sucroferric oxyhydroxide (2500mg)
Overview Dynulta Tablet
Fosrenol tablets effectively manage elevated blood phosphate levels. This medication reduces phosphate concentrations, mitigating complications associated with hyperphosphatemia, especially in dialysis patients with impaired phosphate excretion. Administer Fosrenol with food, consistently following your physician's prescribed schedule for optimal results. Maintaining a regular dosing routine improves adherence. Treatment duration and dosage are tailored to individual needs. Abrupt cessation should be avoided; continue as directed for full therapeutic benefit. Common side effects include altered stool color and diarrhea. Report any adverse reactions, including those listed, to your doctor for appropriate management. Prior to commencing treatment, disclose all pre-existing medical conditions and concurrent medications to your healthcare provider. While generally safe during pregnancy and lactation, consult your doctor to confirm suitability.
Uses of Dynulta Tablet
Managing hyperphosphatemia
Major Benefits of Dynulta Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Dynulta Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Administer Dynulta with food.
Common Side effects of Dynulta Tablet:
- Discoloration of stool
- Diarrhea
- Nausea
- Taste change
How to use Dynulta Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dynulta Tablets should be administered with a meal.
How Dynulta Tablet works:
Sucroferric oxyhydroxide, the active ingredient in Dynulta tablets, is a non-calcium phosphate binder. By binding dietary phosphate within the gastrointestinal system during meals, it inhibits phosphate absorption into the bloodstream, thus managing elevated blood phosphate levels.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Dynulta Tablet may pose unknown risks. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Using Dynulta tablets during pregnancy is considered unsafe due to confirmed risks to the fetus. Nevertheless, a physician might exceptionally prescribe it in life-threatening circumstances where the potential advantages outweigh the hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Dynulta Tablets while breastfeeding is likely inadvisable. Available human data indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Dynulta Tablet on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Individuals with kidney impairment can safely use Dynulta tablets without requiring any modification to the prescribed dosage.
LiverCONSULT YOUR DOCTOR
Data regarding Dynulta Tablet use in individuals with hepatic impairment is currently scarce. Physician consultation is advised.
What if you forget to take Dynulta Tablet :
Should you forget a Dynulta Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dynulta Tablet
| Label | Value |
|---|---|
| Chemical Type | Glycosylated compounds |
| Developing Good Habits | No. |
| Type of Treatment | KINSHIP |






